Lowell Blake & Associates’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$9.92M	Buy	143,242 +13,121	+10%	+$1.05M	2.8%	14
2023 Q2	$12.3M	Sell	130,121 -1,081	-0.8%	-$94K	3.56%	12
2023 Q1	$10.9M	Sell	131,202 -344	-0.3%	-$27K	3.38%	15
2022 Q4	$9.81M	Buy	131,546 +22,979	+21%	+$1.77M	3.28%	15
2022 Q3	$8.97M	Buy	108,567 +7,834	+8%	+$754K	3.51%	14
2022 Q2	$9.58M	Buy	100,733 +22,416	+29%	+$2.32M	3.7%	12
2022 Q1	$9.22M	Buy	78,317 +10,437	+15%	+$1.17M	3.48%	12
2021 Q4	$8.79M	Buy	67,880 +6,579	+11%	+$767K	3.45%	12
2021 Q3	$6.94M	Sell	61,301 -1,321	-2%	-$151K	3.22%	14
2021 Q2	$6.49M	Sell	62,622 -1,679	-3%	-$158K	2.98%	16
2021 Q1	$5.38M	Buy	64,301 +18,329	+40%	+$1.55M	2.75%	17
2020 Q4	$4.19M	Buy	45,972 +1,377	+3%	+$114K	3.1%	17
2020 Q3	$3.56M	Buy	44,595 +5,570	+14%	+$435K	2.87%	17
2020 Q2	$2.7M	Buy	39,025 +6,871	+21%	+$488K	2.58%	19
2020 Q1	$2.02M	Buy	32,154 +7,356	+30%	+$530K	2.6%	18
2019 Q4	$1.93M	Buy	+24,798	New	+$1.94M	2.13%	22